Abstract
Patients with hypoparathyroidism often have many complaints that suggest poor quality of life (QOL). There is a large intra- and interindividual variability in these impairments, which is not clearly explained by the underlying biochemical differences. Formal studies of QOL in this disease are becoming available but do suffer from the lack of disease-specific instruments. Such instruments would be helpful for quantifying the subjective experiences that patients have when on conventional therapy as well as in response to PTH and its analogs. Further studies are also needed to understand the mechanisms of QOL deficits and their relationship to biochemical control.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mannstadt M, et al. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013;1(4):275–83.
Buttner M, Musholt TJ, Singer S. Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine. 2017;58(1):14–20.
Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359(4):391–403.
Shoback DM, et al. Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab. 2016;101(6):2300–12.
Santonati A, et al. PTH(1-34) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life. J Clin Endocrinol Metab. 2015;100(9):3590–7.
Arlt W, et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol. 2002;146(2):215–22.
Sikjaer T, et al. Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism. J Bone Miner Res. 2016;31(7):1440–8.
Cho NL, et al. Surgeons and patients disagree on the potential consequences from hypoparathyroidism. Endocr Pract. 2014;20(5):427–46.
Underbjerg L, et al. Postsurgical hypoparathyroidism – risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res. 2014;29(11):2504–10.
Underbjerg L, et al. The epidemiology of nonsurgical hypoparathyroidism in Denmark: a Nationwide Case Finding Study. J Bone Miner Res. 2015;30(9):1738–44.
Astor MC, et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab. 2016;101(8):3045–53.
Cusano NE, et al. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J Clin Endocrinol Metab. 2014;99(10):3694–9.
Cusano NE, et al. The effect of PTH(1-84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab. 2013;98(6):2356–61.
Palermo A, et al. PTH(1-34) for surgical hypoparathyroidism: a 2-year prospective, open-label investigation of efficacy and quality of life. J Clin Endocrinol Metab. 2018;103(1):271–80.
Sikjaer T, et al. Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int. 2014;25(6):1717–26.
Vokes TJ, et al. Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism. J Clin Endocrinol Metab. 2018;103(2):722–31.
Winer KK. Does PTH replacement therapy improve quality of life in patients with chronic hypoparathyroidism? J Clin Endocrinol Metab. 2018;103(7):2752–5.
Conflict of Interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vokes, T. (2020). Hypoparathyroidism and Quality of Life. In: Cusano, N. (eds) Hypoparathyroidism. Springer, Cham. https://doi.org/10.1007/978-3-030-29433-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-29433-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29432-8
Online ISBN: 978-3-030-29433-5
eBook Packages: MedicineMedicine (R0)